Daniel A. Sweeney

5.9k total citations · 3 hit papers
37 papers, 3.4k citations indexed

About

Daniel A. Sweeney is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Infectious Diseases. According to data from OpenAlex, Daniel A. Sweeney has authored 37 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Critical Care and Intensive Care Medicine and 10 papers in Infectious Diseases. Recurrent topics in Daniel A. Sweeney's work include Nosocomial Infections in ICU (9 papers), Sepsis Diagnosis and Treatment (8 papers) and Pneumonia and Respiratory Infections (6 papers). Daniel A. Sweeney is often cited by papers focused on Nosocomial Infections in ICU (9 papers), Sepsis Diagnosis and Treatment (8 papers) and Pneumonia and Respiratory Infections (6 papers). Daniel A. Sweeney collaborates with scholars based in United States, Spain and Brazil. Daniel A. Sweeney's co-authors include André C. Kalil, Grant Waterer, Michael Klompas, Lucy B. Palmer, Ali A. El Solh, Marcos I. Restrepo, John Muscedere, Santiago Ewig, Naomi P. O’Grady and John G. Bartlett and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and Critical Care Medicine.

In The Last Decade

Daniel A. Sweeney

35 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

2016 2.3k citations André C. Kalil, Mark L. Metersky et al. Clinical Infectious Diseases profile →
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

2016 289 citations André C. Kalil, Mark L. Metersky et al. Clinical Infectious Diseases profile →
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians

2023 134 citations Pedro Póvoa, Luís Coelho et al. Intensive Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel A. Sweeney United States	17	1.9k	1.7k	762	637	569	37	3.4k
Despoina Koulenti Greece	32	1.6k 0.9×	1.2k 0.7×	872 1.1×	471 0.7×	527 0.9×	80	3.2k
Pieter Depuydt Belgium	35	1.8k 0.9×	1.3k 0.8×	553 0.7×	625 1.0×	1.1k 1.9×	100	4.0k
Jean‐Ralph Zahar France	38	2.1k 1.1×	1.2k 0.7×	1.1k 1.4×	628 1.0×	688 1.2×	154	5.1k
Jean-Yves Fagon France	16	2.3k 1.2×	2.8k 1.7×	753 1.0×	582 0.9×	1.2k 2.1×	25	4.3k
Carlos M. Luna Argentina	29	3.1k 1.6×	2.2k 1.4×	896 1.2×	634 1.0×	982 1.7×	72	4.6k
Gennaro De Pascale Italy	31	1.2k 0.6×	698 0.4×	1.0k 1.3×	643 1.0×	621 1.1×	112	3.3k
José Artur Paiva Portugal	29	2.4k 1.2×	1.5k 0.9×	700 0.9×	798 1.3×	716 1.3×	149	4.9k
Paula Ramírez Spain	30	1.7k 0.9×	871 0.5×	358 0.5×	387 0.6×	465 0.8×	121	3.0k
Sameer S. Kadri United States	32	2.6k 1.4×	941 0.6×	657 0.9×	739 1.2×	282 0.5×	101	4.8k
Håkan Hanberger Sweden	31	1.3k 0.7×	1.0k 0.6×	1.4k 1.8×	1.2k 1.8×	431 0.8×	106	4.0k

Countries citing papers authored by Daniel A. Sweeney

Since Specialization

Citations

This map shows the geographic impact of Daniel A. Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Sweeney more than expected).

Fields of papers citing papers by Daniel A. Sweeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Sweeney. The network helps show where Daniel A. Sweeney may publish in the future.

Co-authorship network of co-authors of Daniel A. Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Sweeney. A scholar is included among the top collaborators of Daniel A. Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Sweeney. Daniel A. Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Póvoa, Pedro, Luís Coelho, Jordi Carratalà, et al.. (2025). How to approach a patient hospitalized for pneumonia who is not responding to treatment?. Intensive Care Medicine. 51(5). 893–903. 4 indexed citations

Póvoa, Pedro, Luís Coelho, Adrián Ceccato, et al.. (2024). Biomarkers in pulmonary infections: a clinical approach. Annals of Intensive Care. 14(1). 113–113. 15 indexed citations

Sweeney, Daniel A., Suzana M. Lobo, Pedro Póvoa, & André C. Kalil. (2024). Choosing immunomodulating therapies for the treatment of COVID-19: recommendations based on placebo-controlled trial evidence. Clinical Microbiology and Infection. 30(5). 611–618. 9 indexed citations

Póvoa, Pedro, Luís Coelho, Felipe Dal‐Pizzol, et al.. (2023). How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Medicine. 49(2). 142–153. 134 indexed citations breakdown →

Rhee, Chanu, Jeffrey R. Strich, Kathleen Chiotos, et al.. (2023). Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper. Clinical Infectious Diseases. 78(3). 505–513. 20 indexed citations

Kelly, J. Daniel, Mark Berry, Linda Chen, et al.. (2023). SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis. European Respiratory Review. 32(169). 220254–220254. 16 indexed citations

Fintzi, Jonathan, Tyler Bonnett, Pablo Tebas, et al.. (2022). Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2. Open Forum Infectious Diseases. 9(7). ofac219–ofac219. 2 indexed citations

Fintzi, Jonathan, Tyler Bonnett, Daniel A. Sweeney, et al.. (2021). Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization. Clinical Infectious Diseases. 74(12). 2209–2217. 11 indexed citations

Sweeney, Daniel A. & Anil K. Malhotra. (2021). Coronavirus disease 2019 respiratory failure: what is the best supportive care for patients who require ICU admission?. Current Opinion in Critical Care. 27(5). 462–467. 4 indexed citations

10.

Chopyk, Jessica, Kevan Akrami, Ji Hyun Shin, et al.. (2020). Temporal variations in bacterial community diversity and composition throughout intensive care unit renovations. Microbiome. 8(1). 86–86. 20 indexed citations

11.

Sweeney, Daniel A. & André C. Kalil. (2019). Why don't we have more inhaled antibiotics to treat ventilator-associated pneumonia?. Clinical Microbiology and Infection. 25(10). 1195–1199. 19 indexed citations

12.

Wooten, Darcy, et al.. (2019). Predictors of Acute Liver Failure in Patients With Acute Hepatitis A: An Analysis of the 2016–2018 San Diego County Hepatitis A Outbreak. Open Forum Infectious Diseases. 6(11). ofz467–ofz467. 11 indexed citations

13.

Kalil, André C., Mark L. Metersky, Michael Klompas, et al.. (2016). Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases. 63(5). e61–e111. 2347 indexed citations breakdown →

14.

Sweeney, Daniel A.. (2015). Point-of-Care Ultrasound. Critical Care Medicine. 43(8). e330–e330. 3 indexed citations

15.

Hicks, Caitlin W., Daniel A. Sweeney, Xizhong Cui, Yan Li, & Peter Q. Eichacker. (2012). An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Medicine. 38(7). 1092–1104. 76 indexed citations

16.

Hicks, Caitlin W., Daniel A. Sweeney, Robert L. Danner, et al.. (2012). Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia. Intensive Care Medicine. 38(12). 2063–2071. 18 indexed citations

17.

Sweeney, Daniel A., Caitlin W. Hicks, Xizhong Cui, Yan Li, & Peter Q. Eichacker. (2011). Anthrax Infection. American Journal of Respiratory and Critical Care Medicine. 184(12). 1333–1341. 114 indexed citations

18.

Hicks, Caitlin W., Xizhong Cui, Daniel A. Sweeney, et al.. (2011). The Potential Contributions of Lethal and Edema Toxins to the Pathogenesis of Anthrax Associated Shock. Toxins. 3(9). 1185–1202. 20 indexed citations

19.

Sweeney, Daniel A., Charles Natanson, Steven M. Banks, Steven B. Solomon, & Ellen N. Behrend. (2010). Defining normal adrenal function testing in the intensive care unit setting: A canine study*. Critical Care Medicine. 38(2). 553–561. 6 indexed citations

20.

Sweeney, Daniel A., et al.. (1996). Severe Hyperkalemia in a Geriatric Patient Receiving Standard Doses of Trimethoprim-Sulfamethoxazole. The American Journal of the Medical Sciences. 311(2). 84–85. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact